Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

146 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A Clinical and Molecular Phase II Trial of Oral ENMD-2076 in Ovarian Clear Cell Carcinoma (OCCC): A Study of the Princess Margaret Phase II Consortium.
Lheureux S, Tinker A, Clarke B, Ghatage P, Welch S, Weberpals JI, Dhani NC, Butler MO, Tonkin K, Tan Q, Tan DSP, Brooks K, Ramsahai J, Wang L, Pham NA, Shaw PA, Tsao MS, Garg S, Stockley T, Oza AM. Lheureux S, et al. Among authors: stockley t. Clin Cancer Res. 2018 Dec 15;24(24):6168-6174. doi: 10.1158/1078-0432.CCR-18-1244. Epub 2018 Aug 14. Clin Cancer Res. 2018. PMID: 30108107 Clinical Trial.
A Canadian guideline on the use of next-generation sequencing in oncology.
Yip S, Christofides A, Banerji S, Downes MR, Izevbaye I, Lo B, MacMillan A, McCuaig J, Stockley T, Yousef GM, Spatz A. Yip S, et al. Among authors: stockley t. Curr Oncol. 2019 Apr;26(2):e241-e254. doi: 10.3747/co.26.4731. Epub 2019 Apr 1. Curr Oncol. 2019. PMID: 31043833 Free PMC article.
[No title available]
[No authors listed] [No authors listed] PMID: 33704205
Tissue Prior to the Initial Hematoxylin-Eosin Section Demonstrates Value as an Alternative Source of DNA for Molecular Testing.
Sabatini P, Ta R, Peralta M, Anderson M, Khan S, Belcastro R, Arruda A, Minden MD, Cabanero M, Prica A, Zhang T, Kridel R, Stockley T, Xia D. Sabatini P, et al. Among authors: stockley t. Arch Pathol Lab Med. 2024 Dec 31. doi: 10.5858/arpa.2024-0222-OA. Online ahead of print. Arch Pathol Lab Med. 2024. PMID: 39786946 Free article.
Correction: Incorporating Alternative Polygenic Risk Scores into the BOADICEA Breast Cancer Risk Prediction Model.
Mavaddat N, Ficorella L, Carver T, Lee A, Cunningham AP, Lush M, Dennis J, Tischkowitz M, Downes K, Hu D, Hahnen E, Schmutzler RK, Stockley TL, Downs GS, Zhang T, Chiarelli AM, Bojesen SE, Liu C, Chung WK, Pardo M, Feliubadaló L, Balmaña J, Simard J, Antoniou AC, Easton DF. Mavaddat N, et al. Among authors: stockley tl. Cancer Epidemiol Biomarkers Prev. 2025 Jan 9;34(1):205. doi: 10.1158/1055-9965.EPI-24-1661. Cancer Epidemiol Biomarkers Prev. 2025. PMID: 39780621 Free PMC article. No abstract available.
Analysis of outcomes in resected early-stage NSCLC with rare targetable driver mutations.
Ghazali N, Feng J, Hueniken K, Khan K, Balaratnam K, Waddell TK, Yasufuku K, Pierre A, Donahoe L, Wakeam E, Cypel M, Yeung J, Keshavjee S, de Perrot M, Leighl NB, Liu G, Bradbury PA, Sacher A, Eng L, Stockley T, Tsao MS, Shepherd FA. Ghazali N, et al. Among authors: stockley t. Ther Adv Med Oncol. 2024 Dec 23;16:17588359241308466. doi: 10.1177/17588359241308466. eCollection 2024. Ther Adv Med Oncol. 2024. PMID: 39734710 Free PMC article.
146 results